ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

MOLN Molecular Partners AG

3.78
-0.09 (-2.33%)
Última actualización: 11:47:22
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Molecular Partners AG MOLN NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.09 -2.33% 3.78 11:47:22
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.80 3.75 3.80 3.87
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/5/202405:25EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
16/5/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/5/202415:00GLOBEInterim Management Statement Q1 2024 of Molecular Partners:..
29/4/202410:00GLOBEMolecular Partners Announces Publication in Cancer..
19/4/202410:12GLOBELife Science Cares Launches in Switzerland
17/4/202410:12GLOBEMolecular Partners Announces All Board Proposals Approved at..
26/3/202408:26GLOBEMolecular Partners Publishes Invitation to Annual General..
14/3/202415:00GLOBEMolecular Partners Reports Corporate Highlights From Q4 2023..
01/3/202415:00GLOBEMolecular Partners To Hold Conference Call to Discuss Fourth..
08/1/202411:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/1/202415:00GLOBEMolecular Partners Provides Updates at 42nd Annual J.P...
05/1/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202415:00GLOBEMolecular Partners and Orano Med Announce Co-Development..
14/12/202300:00GLOBEMolecular Partners to Present at 42nd Annual J.P. Morgan..
10/12/202311:00GLOBEMolecular Partners Presents Positive Initial Data from First..
14/11/202300:00GLOBEMolecular Partners to Present on DARPin Oncology Innovations..
03/11/202311:00GLOBEMolecular Partners Presents Updated Positive Data from..
02/11/202305:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202301:00GLOBEMolecular Partners to Present Initial Data from Ongoing..
01/11/202301:00GLOBEMolecular Partners to Participate in the TD Cowen 7th Annual..
26/10/202315:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202315:00GLOBEMolecular Partners Interim Management Statement Q3 2023:..
13/9/202300:00GLOBEMolecular Partners Presents New Data on its Radio DARPin..
24/8/202315:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/8/202315:00GLOBEMolecular Partners Reports H1 2023 Corporate Highlights and..
28/6/202307:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/6/202300:00GLOBEMolecular Partners to Present on its Radio DARPin Therapy..
19/6/202311:00GLOBEMolecular Partners to Present at The TD Cowen..
25/5/202316:01GLOBEMolecular Partners to Present Positive Data from Ongoing..

Su Consulta Reciente

Delayed Upgrade Clock